Your browser doesn't support javascript.
loading
Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.
van Rees, Dieke J; Bouti, Panagiota; Klein, Bart; Verkuijlen, Paul J H; van Houdt, Michel; Schornagel, Karin; Tool, Anton T J; Venet, David; Sotiriou, Christos; El-Abed, Sarra; Izquierdo, Miguel; Guillaume, Sébastien; Saura, Cristina; Di Cosimo, Serena; Huober, Jens; Roylance, Rebecca; Kim, Sung-Bae; Kuijpers, Taco W; van Bruggen, Robin; K van den Berg, Timo; Matlung, Hanke L.
Afiliación
  • van Rees DJ; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
  • Bouti P; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands P.Bouti@sanquin.nl.
  • Klein B; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
  • Verkuijlen PJH; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
  • van Houdt M; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
  • Schornagel K; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
  • Tool ATJ; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
  • Venet D; Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Bruxelles, Belgium.
  • Sotiriou C; Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Bruxelles, Belgium.
  • El-Abed S; Breast International Group, Brussels, Belgium.
  • Izquierdo M; Novartis Pharma AG, Basel, Switzerland.
  • Guillaume S; Department of Psychiatric Emergency & Acute Care, Lapeyronie Hospital, Montpellier, France.
  • Saura C; SOLTI Innovative Breast Cancer Research, Vall d'Hebron Hospital Universitari, Barcelona, Spain.
  • Di Cosimo S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Huober J; Breast Center, University of Ulm, Ulm, Germany.
  • Roylance R; Department of Oncology, University College London Hospitals NHS Foundation Trust and NIHR University College London Hospitals Biomedical Research Centre, London, UK.
  • Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kuijpers TW; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
  • van Bruggen R; Department of Pediatric Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • K van den Berg T; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
  • Matlung HL; Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
J Immunother Cancer ; 10(6)2022 06.
Article en En | MEDLINE | ID: mdl-35728876
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neutrófilos Límite: Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neutrófilos Límite: Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos